You have 9 free searches left this month | for more free features.

City

New York (1)

Condition

Central Nervous System/Leptomeningeal Neoplasms (1)

DIPG (1)

Overall Status

Available (1)

Not yet recruiting (1)

Phase

phase 1 (1)

Sponsor

Memorial Sloan Kettering Cancer Center (1)

Y-mAbs Therapeutics (1)

Collaborator

Invicro (1)

Labcorp Drug Development Inc (1)

Y-mAbs Therapeutics (1)

Intervention

131i-omburtamab (2)

convention enhanced delivery (1)

Study Documents

Intervention Type

drug (2)

device (1)

Funder Type

Industry (1)

Other (1)

Study Type

Expanded Access (1)

Interventional (1)

131i-omburtamab

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

CNS/Leptomeningeal Tumors Trial in New York (131I-omburtamab)

Available

Central Nervous System/Leptomeningeal Neoplasms

131I-omburtamab

New York, New York

Memorial Sloan Kettering Cancer Center

Jul 15, 2022

DIPG Trial (131I-Omburtamab, Convention Enhanced Delivery)

Not yet recruiting

DIPG

131I-Omburtamab
Convention Enhanced Delivery

(no location specified)

Feb 7, 2022